Pancreatic resection pain management: is combining PCA therapy and a continuous local infusion of 0.5% ropivacaine beneficial?
Thompson
Traci K
TK
Hutchison
Rob W
RW
Wegmann
Deborrah J
DJ
Shires
G Tom
GT
Beecherl
Ernest
E
D000328:Adult; D000577:Amides / Q000008:administration & dosage*; D016058:Analgesia, Patient-Controlled; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D000779:Anesthetics, Local / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007260:Infusion Pumps; D007263:Infusions, Parenteral; D008297:Male; D010147:Pain Measurement; D010149:Postoperative Pain / Q000209:etiology / Q000517:prevention & control*; D010180:Pancreatectomy / Q000009:adverse effects*; D016577:Pancreaticoduodenectomy / Q000009:adverse effects*; D012189:Retrospective Studies; D000077212:Ropivacaine; D016896:Treatment Outcome
D000577:Amides; D000701:Analgesics, Opioid; D000779:Anesthetics, Local; D000077212:Ropivacaine